7.00 USD
▲+0.15+2.19%
盘后 7.03 +0.39%
2026-09-15
市值
$2.66B
市盈率
—
EPS
-0.98
股息率
—
52 周区间
2.99 – 7.72
成交量
2.78M
Beta
1.02
目标价
14.50
52W 低 2.9952W 高 7.72
价格走势
公司简介
Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. The company offers therapeutic platforms consisting of AdenoVerse platform, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine antigen; and UltraCAR-T to provide chimeric antigen receptor T cell therapies for cancer patients. It also develops pro...